Statins might help to overcome resistance that certain cancers have to immunotherapy.
Quoted:
These findings help explain why immune checkpoint inhibitors fail in many patients. By uncovering a new mechanism that controls the release of immunosuppressive PD-L1 through extracellular vesicles, the study reveals a previously hidden contributor to immune resistance.
The connection to statins is especially significant because these medications are widely prescribed, affordable, and generally safe. This raises the possibility that the discovery could be translated into clinical use relatively quickly. As the researchers noted, “In the long term, this research may lead to more effective and accessible cancer immunotherapies. It could help more patients benefit from immune checkpoint treatments, improving survival and quality of life in real-world settings.”
scitechdaily.comA Common Drug May Make Cancer Immunotherapy Work BetterA newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.scitechdaily.com


